clopidogrel has been researched along with Vascular Diseases in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.52) | 18.2507 |
| 2000's | 21 (45.65) | 29.6817 |
| 2010's | 20 (43.48) | 24.3611 |
| 2020's | 2 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Kanny, O; Khan, H; Qadura, M; Syed, MH | 1 |
| Oluwole, AS; Virk, HUH; Witzke, C | 1 |
| Adawi, S; Bardicef, M; Gutterman, E; Rubinshtein, R; Shiran, A | 1 |
| Chen, JY; Deng, CY; Fu, YH; Han, YL; Lei, HP; Li, XH; Lin, YB; Sheng, WS; Tang, QJ; Wu, H; Zhong, SL | 1 |
| Bendinelli, V; Daper, A; Lefebvre, P | 1 |
| Collins, MB; Gaba, P; Parikh, SA | 1 |
| Arrich, J; Gouya, G; Gurbel, PA; Huber, K; Pirker-Kees, A; Siller-Matula, JM; Verheugt, FW; Wolzt, M | 1 |
| Beattie, D; Burkes, M; Cruickshank, R; Smith, L | 1 |
| Abdullah, AS; Ibrahim, H; Kiernan, TJ | 1 |
| Liu, W; Wu, S; Zhou, Y | 1 |
| Berringer, R; Wonnacott, D | 1 |
| Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S | 1 |
| Chrolavicius, S; Connolly, SJ; Hart, RG; Hohnloser, SH; Pfeffer, M; Pogue, J; Yusuf, S | 1 |
| Chua, D; Legal, M; Shalansky, SJ | 1 |
| Abraham, NG; Ferraris, A; Kruger, AL; McClung, JA; Tsenovoy, P; Vanella, L; Weiss, MB | 1 |
| Gladding, P; Webster, M; White, H | 1 |
| Berger, PB; Bhatt, DL; Brennan, DM; Fox, KA; Fuster, V; Hacke, W; Montalescot, G; Shao, M; Steg, PG; Steinhubl, SR; Topol, EJ | 1 |
| Bhatt, DL; Boden, WE; Flather, MD | 1 |
| Ait-Mokhtar, O; Arnaud, L; Baumstarck-Barrau, K; Bonello, L; Camoin-Jau, L; Dignat-George, F; Harhouri, K; Lesavre, N; Paganelli, F; Piot, C; Roubille, F; Sabatier, F | 1 |
| Duckers, HJ; Rudez, G; Simoons, ML | 1 |
| Rao, GH | 1 |
| Dawson, J; Stewart, K; Walters, M | 1 |
| Bath, PM; Cotton, D; Diener, HC; Donnan, GA; Martin, RH; Ovbiagele, B; Vinisko, R; Yusuf, S | 1 |
| Douglas, IJ; Evans, SJ; Grosso, AM; Hemingway, H; Hingorani, AD; Smeeth, L; Timmis, A | 1 |
| Reinhart, WH | 1 |
| Rodgers, JE; Steinhubl, SR | 1 |
| Owens, DK; Schleinitz, MD; Weiss, JP | 1 |
| Griffin, S; Hawkins, N; Henderson, R; Jones, L; Main, C; Orton, V; Palmer, S; Riemsma, R; Sculpher, M; Sudlow, C | 1 |
| Beckman, JA; Jaff, MR; Jang, J; Olin, JW; Rooke, T | 1 |
| Akehurst, R; Brennan, A; Coshall, C; Fowkes, G; Gray, D; Karnon, J; Lee, A; Nicholls, C; Pandor, A | 1 |
| Hansen, DB | 1 |
| Bavry, AA; Lincoff, AM | 1 |
| Lindhoff-Last, E; Mani, H | 1 |
| Mattle, H; Niederkorn, K | 1 |
| Atar, D; Hanley, DF; Malinin, AI; Serebruany, VL | 1 |
| Bowry, AD; Brookhart, MA; Choudhry, NK | 1 |
| Kapoor, JR | 1 |
| McCarthy, C; Roberti, I; Vyas, S | 1 |
| Avorn, J; Choudhry, NK; Levin, R | 1 |
| Hermosillo, AJ; Spinler, SA | 1 |
| Ferguson, JJ; Gonzalez, ER; Kannel, WB; Olin, JW; Raps, EC | 1 |
| D'Sa, S; Machin, SJ | 1 |
| Aronow, WS | 1 |
| Diot, E; Gruel, Y; Guilmot, JL | 1 |
| Chen, AH; Frangos, SG; Sumpio, B | 1 |
| Mehta, SR; Yusuf, S | 1 |
13 review(s) available for clopidogrel and Vascular Diseases
| Article | Year |
|---|---|
Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Factor X; Humans; Platelet Aggregation Inhibitors; Point-of-Care Testing; Rivaroxaban; Ticagrelor; Vascular Diseases | 2022 |
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Topics: Adenosine; Aged; Aspirin; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel; Cohort Studies; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Population; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Secondary Prevention; Stroke; Thiophenes; Ticagrelor; Ticlopidine; Vascular Diseases | 2014 |
Spontaneous coronary artery dissection: Case report and review of the literature.
Topics: Acute Coronary Syndrome; Adrenergic beta-1 Receptor Antagonists; Adult; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Echocardiography; Electrocardiography; Female; Humans; Metoprolol; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 2016 |
Management of type-2 diabetes with anti-platelet therapies: special reference to aspirin.
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Thienopyridines; Ticlopidine; Vascular Diseases | 2011 |
Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Stents; Ticlopidine; Treatment Outcome; Vascular Diseases | 2003 |
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Diarrhea; Dipyridamole; Drug Costs; Drug Eruptions; Dyspepsia; Evidence-Based Medicine; Hemorrhage; Humans; Ischemia; Models, Econometric; Nausea; Platelet Aggregation Inhibitors; Research Design; Risk Factors; Ticlopidine; Treatment Outcome; Vascular Diseases; Vomiting | 2004 |
The top 12 advances in vascular medicine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Clopidogrel; Factor V; Heparin, Low-Molecular-Weight; Hot Temperature; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Mutation; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation Inhibitors; Purines; Sildenafil Citrate; Sulfones; Tetrazoles; Thrombin; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures | 2004 |
Is clopidogrel cardiovascular medicine's double-edged sword?
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 2006 |
[Resistance to acetylsalicylic acid and clopidogrel: current status].
Topics: Aspirin; Clopidogrel; Drug Monitoring; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 2006 |
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome; Vascular Diseases | 2008 |
Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine; Vascular Diseases; Warfarin | 2008 |
Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Topics: Aged; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 1999 |
Vascular drugs in the new millennium.
Topics: Abciximab; Animals; Anistreplase; Antibodies, Monoclonal; Anticoagulants; Aspirin; Chondroitin Sulfates; Clopidogrel; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Immunoglobulin Fab Fragments; Intermittent Claudication; Platelet Aggregation Inhibitors; Streptokinase; Ticlopidine; Vascular Diseases; Venous Thrombosis | 2000 |
5 trial(s) available for clopidogrel and Vascular Diseases
| Article | Year |
|---|---|
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Vascular Diseases | 2008 |
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vascular Diseases; Vitamin K | 2009 |
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHAR
Topics: Aged; Aspirin; Clopidogrel; Disease Management; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Risk Factors; Survival Rate; Thrombosis; Ticlopidine; Vascular Diseases | 2010 |
Level of adenosine diphosphate receptor P2Y12 blockade during percutaneous coronary intervention predicts the extent of endothelial injury, assessed by circulating endothelial cell measurement.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Endothelial Cells; Endothelium, Vascular; Female; Humans; Male; Platelet Aggregation Inhibitors; Predictive Value of Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine; Vascular Diseases | 2010 |
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
Topics: Angina, Unstable; Aspirin; Clopidogrel; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Vascular Diseases | 2000 |
28 other study(ies) available for clopidogrel and Vascular Diseases
| Article | Year |
|---|---|
Intense exercise may not be so benign: chest pain in a young athletic woman may be spontaneous coronary artery dissection (SCAD).
Topics: Adult; Aspirin; Chest Pain; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Coronary Vessels; Electrocardiography; Female; Humans; Physical Exertion; Platelet Aggregation Inhibitors; Treatment Outcome; Troponin; Ultrasonography, Interventional; Vascular Diseases | 2020 |
Non-invasive management of post-partum spontaneous left main coronary artery dissection using cardiac computed tomography angiography.
Topics: Adult; Aspirin; Bisoprolol; Cesarean Section; Clopidogrel; Computed Tomography Angiography; Conservative Treatment; Coronary Angiography; Coronary Vessel Anomalies; Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Postpartum Period; Pregnancy; ST Elevation Myocardial Infarction; Ticlopidine; Treatment Outcome; Troponin T; Vascular Diseases | 2017 |
Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Clopidogrel; Coronary Artery Disease; Female; Heart Diseases; Hemorrhage; Humans; Male; MicroRNAs; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Vascular Diseases | 2019 |
Spontaneous Coronary Artery Dissection in the Postoperative Period: A Case Report.
Topics: Adult; Aspirin; Bisoprolol; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Female; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hysterectomy, Vaginal; Postoperative Period; Vascular Diseases | 2019 |
A Woman With Multiparity Experiencing Chest Pain in Her Early 60s.
Topics: Adrenergic beta-Antagonists; Aspirin; Chest Pain; Clopidogrel; Coronary Vessel Anomalies; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Parity; Vascular Diseases | 2019 |
Tips for GP trainees working in vascular surgery.
Topics: Anticholesteremic Agents; Aspirin; Blood Pressure; Clinical Competence; Clopidogrel; Education, Medical, Graduate; General Practice; Humans; Learning; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Simvastatin; Smoking Cessation; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures | 2014 |
Spontaneous coronary artery dissection: a complete resolution with medical treatment.
Topics: Adult; Aspirin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Vascular Diseases | 2014 |
Spontaneous coronary artery dissection in the presence of myocardial bridge causing myocardial infarction: an insight into mechanism.
Topics: Adult; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Female; Humans; Myocardial Bridging; Myocardial Infarction; Perindopril; Ticlopidine; Treatment Outcome; Vascular Diseases | 2016 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Embolism; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vascular Diseases | 2009 |
Usefulness of clopidogrel to protect against diabetes-induced vascular damage.
Topics: Adult; Aged; Cell Count; Clopidogrel; Diabetes Complications; Diabetes Mellitus, Type 2; Endothelial Cells; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 2010 |
Prasugrel, Māori, and personalised medicine in New Zealand.
Topics: Aryl Hydrocarbon Hydroxylases; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Genetic Markers; Genetic Testing; Humans; Native Hawaiian or Other Pacific Islander; Pharmacogenetics; Piperazines; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Precision Medicine; Stents; Thiophenes; Thrombosis; Ticlopidine; Vascular Diseases | 2010 |
Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective.
Topics: Aspirin; Clopidogrel; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Thrombosis; Ticlopidine; Time Factors; Vascular Diseases | 2010 |
Clopidogrel and endothelial injury after percutaneous coronary interventions: beyond the antiplatelet effects.
Topics: Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Endothelium, Vascular; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prosthesis Implantation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Ticlopidine; Vascular Diseases | 2010 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90).
Topics: Aspirin; Clopidogrel; Constriction, Pathologic; Delayed-Action Preparations; Dipyridamole; Drugs, Generic; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine; Vascular Diseases | 2011 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Clopidogrel; Diastole; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Reference Values; Risk; Stroke; Systole; Telmisartan; Ticlopidine; Vascular Diseases | 2011 |
Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs.
Topics: Aspirin; Clopidogrel; Cohort Studies; Data Collection; Drug Interactions; Humans; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Research Design; Ticlopidine; Vascular Diseases | 2012 |
Platelets in vascular disease.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Hemostasis; Humans; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Vascular Diseases | 2013 |
Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Fibrinolytic Agents; Humans; Markov Chains; Middle Aged; Platelet Aggregation Inhibitors; Sensitivity and Specificity; Ticlopidine; Vascular Diseases | 2004 |
Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK.
Topics: Aged; Aspirin; Clopidogrel; Cost-Benefit Analysis; Female; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Ticlopidine; United Kingdom; Vascular Diseases | 2005 |
The (variable) definition of benefit in the case of clopidogrel vs aspirin.
Topics: Aspirin; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome; Vascular Diseases | 2005 |
[Clopidogrel versus acetylsalicylic acid in the secondary prophylaxis of vascular diseases. A commentary on the report of the Institute for Quality and Efficiency in the Health Service].
Topics: Academies and Institutes; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemotherapy, Adjuvant; Clopidogrel; Humans; National Health Programs; Platelet Aggregation Inhibitors; Quality Assurance, Health Care; Secondary Prevention; Ticlopidine; Vascular Diseases | 2007 |
Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Integrin beta3; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Function Tests; Platelet Membrane Glycoprotein IIb; Risk Factors; Ticlopidine; Vascular Diseases | 2007 |
Platelet activation and atherothrombosis.
Topics: Acute Coronary Syndrome; Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Vascular Diseases | 2008 |
May-Thurner syndrome in a pediatric renal transplant recipient--case report and literature review.
Topics: Adolescent; Clopidogrel; Creatinine; Edema; Female; Graft Survival; Humans; Iliac Vein; Kidney Diseases; Kidney Transplantation; Lymphocele; Stockings, Compression; Syndrome; Ticlopidine; Treatment Outcome; Vascular Diseases | 2008 |
The economic consequences of non-evidence-based clopidogrel use.
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Evidence-Based Medicine; Female; Humans; Male; Medicare; Pennsylvania; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Quality of Health Care; Retrospective Studies; Ticlopidine; United States; Vascular Diseases | 2008 |
Clinical safety and efficacy of clopidogrel--implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study for future management of atherosclerotic disease.
Topics: Arteriosclerosis; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; United States; Vascular Diseases | 1998 |
Clopidogrel: a novel antiplatelet agent.
Topics: Adenosine Diphosphate; Aspirin; Clopidogrel; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 1999 |
[Contribution of platelet aggregation inhibitors in the prevention of complications of atherothrombosis].
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Risk Factors; Thrombosis; Ticlopidine; Vascular Diseases | 2000 |